The impact of the Trump crew on vaccine take-up is unlikely to be positive. It is difficult to assess the wider impact on the medical field and pharmaceuticals in the US. Whereas support in Oz is relatively strong. Management at MDR will have their abilities tested. Often success in a difficult environment is the making of a company. I am holding to see what they can make of it.
Add to My Watchlist
What is My Watchlist?
